Company Filing History:
2 out of 3 
1 out of 267 
1 out of 3,923 
Years Active: 2010-2025
Title: Ralf Brandt: Innovator in Cancer Treatment
Introduction
Ralf Brandt is a notable inventor based in Greenwith, Australia. He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 4 patents, Brandt's work focuses on developing compositions and methods that aim to improve cancer therapies.
Latest Patents
Brandt's latest patents include a proenzyme composition that relates to methods and kits for treating cancer. This invention specifically involves administering chymotrypsinogen and trypsinogen in certain amounts to effectively treat cancer. The weight ratio of chymotrypsinogen to trypsinogen is crucial, with a recommended ratio greater than 8:1. Another significant patent is a pharmaceutical composition that combines trypsinogen and/or chymotrypsinogen with active agents such as selenium compounds and vanilloid compounds. This composition aims to provide a multi-functional approach to cancer treatment, enhancing cell adhesion, inducing apoptosis, and promoting immunorecognition in tumor cells.
Career Highlights
Throughout his career, Ralf Brandt has worked with various organizations, including Propanc Pty Ltd and the University of Sydney Commercial Development & Industry Partnerships. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer treatments.
Collaborations
Brandt has collaborated with notable individuals in his field, including Julian Norman Kenyon and Paul Rodney Clayton. These partnerships have played a vital role in enhancing his research and expanding the impact of his inventions.
Conclusion
Ralf Brandt's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving healthcare. His work continues to inspire advancements in the field of oncology.